
Sign up to save your podcasts
Or


While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:
By American Society for Clinical Pathology4.6
4848 ratings
While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:

91,037 Listeners

78,780 Listeners

44,007 Listeners

38,847 Listeners

30,124 Listeners

172,145 Listeners

11,041 Listeners

112,882 Listeners

56,980 Listeners

16,985 Listeners

369,658 Listeners

99,602 Listeners

59,614 Listeners

2,311 Listeners

10,522 Listeners